Curtis Gale Oltmans, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 39,440 shares at $18.06 ($712K) on 2019-01-15, disclosed to the SEC on 2019-01-17.
Open-market sale of $712k ARRY by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.06 | 19,720 | $356K | 50.0% |
| 2 | $18.06 | 19,720 | $356K | 50.0% |
| Total | $18.06 avg | 39,440 | $712K | 100% |
| Filing → |
| ARRY | SELL | 2019-02-07 | $800K | — | Filing → |
| ARRY | SELL | 2019-01-29 | $253K | — | Filing → |
| ARRY | SELL | 2019-01-23 | $23K | — | Filing → |